Biosoft presented its project to biomedical business experts on 27th of December 2012 in the scope of Russian Startup Index (RSI) seminar. Russian Startup Index is a rating agency that gives investment attractiveness indexes to startup companies. The results of winter session were announced on January 10th 2013. Biosoft project got a BB rating which corresponds to a high investment attractiveness during the next short-term period. This result was third in the group of winter session biomedical startups and was considered to be a very good characteristic of the Biosoft project.